Cytogenetic and Genome Research

Letter to the Editor

Free Access

Clinical Manifestations of Partial Trisomy 2p

Lurie I.W.

Author affiliations

Chromosome Disorder Outreach, Boca Raton, Fla., USA

Corresponding Author

Iosif W. Lurie

913 Rachel Jordan Court

Owings Mills, MD 21117 (USA)

E-Mail iosifw@gmail.com

Related Articles for ""

Cytogenet Genome Res 2014;144:28-30

Sir,

Martínez-Juárez et al. [2014] reported 2 siblings with trisomy 2p caused by maternal translocation t(2;12)(p22.3q24.3). Neither of these siblings nor several other patients with pure trisomy 2p cited by these authors had congenital diaphragmatic hernia (CDH), neuroblastoma or neural tube defects (NTD). Almost 20 years ago, we [Lurie et al., 1995] suggested that these findings are causally related to trisomy 2p. Martínez-Juárez et al. state that our conclusion was false and that these findings actually are caused by associated chromosomal imbalances.

CDH was reported in 7 patients with trisomy 2p (table 1). Four of these patients had associated deletions for other chromosomes, 1 had mosaic trisomy for the whole 2p and proximal part of 2q (from centromere to 2q11.2) [Kan et al., 2014], and 2 had pure trisomy 2p [Heathcote et al., 1991; Blassnig-Ezeh et al., 2013]. In the latter observation, absence of any associated imbalance was confirmed by molecular methods. Blassnig-Ezeh et al. [2013] narrowed down the critical segment for CDH to approximately 8 Mb (between 42.3 and 50.0 Mb) on 2p21. In that context, there are no reasons to relate the origin of CDH to any chromosomal abnormalities that accompanied trisomy 2p.

Table 1

CDH in individuals with partial trisomy 2p

http://www.karger.com/WebMaterial/ShowPic/153590

At least 11 patients with trisomy 2p developed neuroblastoma (table 2). Two of these patients had pure trisomy 2p [Say et al., 1980; Warad et al., 2012], another had an additional 0.144-Mb duplication of 3q29 and a 0.219-Mb deletion of 20p12.1 [Van Mater et al., 2013]. In the opinion of Martínez-Juárez et al. [2014], a person with an imbalance of this size may be classified as pure duplication 2p. Eight others had an associated imbalance. New data show that duplication of the MYCN locus at 2p24.3 is responsible for the origin of neuroblastoma in patients with trisomy 2p [Lipska et al., 2013].

Table 2

Neuroblastoma in individuals with partial trisomy 2p

http://www.karger.com/WebMaterial/ShowPic/153589

NTD were found in 20 published patients with trisomy 2p (table 3). There are no other partial trisomies where NTD were reported in such a large number of persons. In at least 3 patients [Therkelsen et al., 1973; Thangavelu et al., 2004], anencephaly or spina bifida was found without any associated imbalance.

Table 3

NTD in individuals with partial trisomy 2p

http://www.karger.com/WebMaterial/ShowPic/153588

Of course, several reports of the above-mentioned abnormalities in individuals with pure trisomy 2p were published in the ‘pre-molecular era', and a tiny associated imbalance for other chromosomal segments could not be completely excluded. However, neither of the partial monosomies associated with neuroblastoma (deletions of the distal parts of 7q, 8p, 13q, 16p, 17q, or 18q) are known as causative factors for the origin or this tumor. The same is true for partial monosomies in patients with trisomy 2p and NTD, because these deletions (with the exception of del 13q) are not known as being associated with anencephaly or spina bifida. These facts suggest that trisomy 2p itself but not the associated imbalances are responsible for the origin of NTD.

So, there is strong evidence that all 3 groups of the above-mentioned defects are caused by trisomy 2p, but not by the associated imbalance.

Martínez-Juárez et al. [2014] state that a horseshoe kidney observed in one of their patients is a ‘previously unrecognized defect associated with this syndrome'. Actually, however, horseshoe kidney was reported both in patients with pure trisomy 2p [Cummings et al., 1997] and in association with another imbalance [Larson et al., 1982].

Also, both siblings reported by Martínez-Juárez et al. [2014] were presented by Quintana Palma et al. [2010] at the 35th annual meeting of the Mexican Society of Human Genetics. The published abstract of their presentation states that the boy had unilateral renal agenesis and hypospadias (although in the article they describe these defects as horseshoe kidney and overriding scrotum).

Precise description of the phenotype, thorough and critical review of the literature, as well as care in drawn conclusions are important issues to consider in the writing of any scientific paper.



Related Articles:


References

  1. Bender K, Reinwein H, Gorman LZ, Wolf U: Familiäre 2/C-Translokation: 46,XY,t(2p-;Cp+) und 46,XX,Cp+. Humangenetik 8:94-104 (1969).
  2. Blassnig-Ezeh A, Bandelier C, Frühmesser A, Revencu N, Krabichler B, et al: Severe growth retardation, delayed bone age, and facial dysmorphism in two patients with microduplications in 2p16→p22. Am J Med Genet A 161A:3176-3181 (2013).
  3. Cain CC, Saul DO, Oehler E, Blakemore K, Stetten G: Prenatal detection of a subtle unbalanced chromosome rearrangement by karyotyping, FISH and array comparative genomic hybridization. Fetal Diagn Ther 24:286-290 (2008).
  4. Cummings JH, Surti U, Mowery-Rushton P, Bay CA: Mosaic partial trisomy 2p: completion of chromosomal characterization 17 years after initial visit. Am J Hum Genet 61, Suppl:A372 (1997).
  5. Doray B, Favre R, Gasser B, Girard-Lemaire F, Schluth C, Flori E: Recurrent neural tube defects associated with partial trisomy 2p22-pter: report of two siblings and review of the literature. Genet Couns 14:165-172 (2003).
    External Resources
  6. Dowa Y, Yamamoto T, Abe Y, Kobayashi M, Hoshino R, et al: Congenital neuroblastoma in a patient with partial trisomy of 2p. J Pediatr Hematol Oncol 28:379-382 (2006).
  7. Fineman RM, Buyse M, Morgan M: Variable phenotype associated with duplication of different regions of 2p. Am J Med Genet 15:451-456 (1983).
  8. Gregory L, Davis T, Bonney J, Delmege D, Skirton H, Lunt P: Trisomy for the region 2p25.2 to 2pter with a variable phenotype. J Med Genet 37, Suppl 1:S52 (2000).
  9. Hahm GK, Barth RF, Schauer GM, Reiss R, Opitz JM: Trisomy 2p syndrome: a fetus with anencephaly and postaxial polydactyly. Am J Med Genet 87:45-48 (1999).
  10. Heathcote JG, Sholdice J, Walton JC, Willis NR, Sergovich FR: Anterior segment mesenchymal dysgenesis associated with partial duplication of the short arm of chromosome 2. Can J Ophthalmol 26:35-43 (1991).
    External Resources
  11. Kan ASY, Lau ET, Tang WF, Chan SSY, Ding SCK, et al: Whole-genome array CGH evaluation for replacing prenatal karyotyping in Hong Kong. PLoS One 9:e87988 (2014).
  12. Kim SJ, Kim MJ, Kim MS, Park IY, Hur SY, et al: Prenatal 3D-ultrasound diagnosis of exencephaly associated with partial trisomy 2p and distal 5p deletion. Acta Obstetr Gynaecol Japon 59:775, abstract P1-IS-53 (2007).
  13. Larson LM, Wasdahl WA, Saumur JH, Coleman ML, Hall JG, et al: Familial reciprocal translocation, t(2;10)(p24;q26), resulting in duplication 2p and deletion 10q. Clin Genet 21:187-195 (1982).
  14. León León C, Velázquez Wong AC, Rodríguez Palacios ME, Huicochea Montiel JC, Cárdenas Conejo A, et al: Trisomía parcial de 2p y monosomía parcial de 18p con presencia de dysplasia septoóptica. Asociation Mexicana de Genetica Humana, XXXVI Congresso, Abstract CG6 (2011).
  15. Lipska BS, Koczkowska M, Wierzba J, Ploszynska A, Iliszko M, et al: On the significance of germline cytogenetic rearrangements at MYCN locus in neuroblastoma. Mol Cytogenet 6:43 (2013).
  16. Lurie IW, Ilyina HG, Gurevich DB, Rumyantseva NV, Naumchik IV, et al: Trisomy 2p: analysis of unusual phenotypic findings. Am J Med Genet 55:229-236 (1995).
  17. Martínez-Juárez A, Uribe-Figueroa L, Quintana-Palma M, Razo-Aguilera G, Sevilla-Montoya R: Pure trisomy 2p syndrome in two siblings with an unbalanced translocation and minimal terminal 12q monosomy characterized by high-density microarray. Cytogenet Genome Res 142:249-254 (2014).
  18. Morgenstern DA, Soh SY, Stavropoulos DJ, Bowdin S, Baruchel S, et al: Metachronous neuroblastoma in an infant with germline translocation resulting in partial trisomy 2p: a role for ALK? J Pediatr Hematol Oncol 36:e193-e196 (2014).
  19. Mosca AL, Pinson L, Andrieux J, Copin H, Bigi N, et al: Refining the critical region for congenital diaphragmatic hernia on chromosome 15q26 from the study of four fetuses. Prenat Diagn 31:912-914 (2011).
  20. Nagano H, Kano Y, Kobuchi S, Kajitani T: A case of partial 2p trisomy with neuroblastoma. Jpn J Hum Genet 25:39-45 (1980).
  21. Nowaczyk MJM, Huggins MJ, Tomkins DJ, Rossi E, Woulfe J, et al: Holoprosencephaly, sacral anomalies, and situs ambiguous in an infant with partial monosomy 7q/trisomy 2p and SHH and HLXB9 haploinsufficiency. Clin Genet 57:388-393 (2000).
  22. Patel JS, Pearson J, Willatt L, Andrews T, Beach R, Green A: Germline duplication of chromosome 2p and neuroblastoma. J Med Genet 34:949-951 (1997).
  23. Poulose T, Tsepov D, Fox R: Familial exencephaly-anencephaly sequence and translocation. J Obstet Gynaecol 27:317-318 (2007).
  24. Quintana Palma M, Martínez-Juárez A, Razo Aguilera G, Grether González P, Nieto Martínez K, et al: Características fenotípicas en una pareja de hermanos con trisomía parcial 2p y monosomía parcial 12q resultants de una translocación maternal balanceada 2;12(p22.2;q24.31). Asociation Mexicana de Genetica Humana, XXXV Congresso, Abstract (2010).
  25. Sarda P, Lefort G, Devaux P, Huneau C, Rieu D: Multiple congenital anomalies due to partial 2p13→2pter duplication resulting from an unbalanced X;2 translocation. Ann Genet 35:117-120 (1992).
    External Resources
  26. Say B, Carpenter NJ, Giacoia G, Jegathesan S: Agenesis of the lung associated with a chromosomal abnormality (46,XX,2p+). J Med Genet 17:477-478 (1980).
  27. Singer N, Gersen S, Warburton D: The value of chromosome analysis in cases of neural tube defects: a case of anencephaly associated with fetal dup(2)(p24→pter). Prenat Diagn 7:567-571 (1987).
  28. Stallworth JL, Avert JM, DuPont BR, Lebel RR: Partial trisomy 2p and partial monosomy 9p in a fetus with anencephaly, polydactyly, and other abnormalities. Proc Greenwood Genet Center 27:18-21 (2008).
  29. Stephane R, Genevieve D, Sanlaville D, Maltret A, Serrero S, et al: Trisomy 2p and monosomy 8p in a patient with DiGeorge syndrome. Am J Hum Genet 75, Suppl:266 (2003).
  30. Thangavelu M, Frolich G, Rogers D: Partial duplication 2p as the sole abnormality in two cases with anencephaly. Am J Med Genet A 124A: 170-172 (2004).
  31. Therkelsen AJ, Hultén M, Jonasson J, Lindsten J, Christensen NC, Iversen T: Presumptive direct insertion within chromosome 2 in man. Ann Hum Genet 36:367-373 (1973).
  32. Van Mater D, Knelson EH, Kaiser-Rogers KA, Armstrong MB: Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locus. Am J Med Genet A 161A:605-610 (2013).
  33. Walbaum R, Peyrat MF, van de Velde MF, Guerin du Masgenet B, Bethouart M, Farriaux JP: Fail-il caryotyper les parents d'enfants atteints d'anomalies de fermeture du tube neural? J Genet Hum 32:307 (1984).
  34. Warad D, Kirmani S, Marri Reddy P, Nemergut M, Rodriguez V, Nageswara Rao A: Perinatal neuroblastoma with a germline interstitial 2p duplication involving the MYCN gene: a case report. Arch Dis Child 97 (Suppl 2):A161-A162 (2012).
    External Resources
  35. Wellesley D, Boyle T: Regarding trisomy 2p syndrome. Am J Med Genet 92:295 (2000).
  36. Winsor SH, McGrath MJ, Khalifa M, Duncan AM: A report of recurrent anencephaly with trisomy 2p23-2pter: additional evidence for the involvement of 2p24 in neural tube development and evaluation of the role for cytogenetic analysis. Prenat Diagn 17:665-669 (1997).
  37. Yüksel A, Seven M, Karaman B, Yilmaz S, Deviren A, et al: Neuroblastoma in a dysmorphic girl with a partial duplication of 2p caused by an unbalanced translocation. Clin Dysmorphol 11:39-42 (2002).

Author Contacts

Iosif W. Lurie

913 Rachel Jordan Court

Owings Mills, MD 21117 (USA)

E-Mail iosifw@gmail.com


Article / Publication Details

Accepted: May 09, 2014
Published online: October 14, 2014
Issue release date: November 2014

Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 3

ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)

For additional information: https://www.karger.com/CGR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Bender K, Reinwein H, Gorman LZ, Wolf U: Familiäre 2/C-Translokation: 46,XY,t(2p-;Cp+) und 46,XX,Cp+. Humangenetik 8:94-104 (1969).
  2. Blassnig-Ezeh A, Bandelier C, Frühmesser A, Revencu N, Krabichler B, et al: Severe growth retardation, delayed bone age, and facial dysmorphism in two patients with microduplications in 2p16→p22. Am J Med Genet A 161A:3176-3181 (2013).
  3. Cain CC, Saul DO, Oehler E, Blakemore K, Stetten G: Prenatal detection of a subtle unbalanced chromosome rearrangement by karyotyping, FISH and array comparative genomic hybridization. Fetal Diagn Ther 24:286-290 (2008).
  4. Cummings JH, Surti U, Mowery-Rushton P, Bay CA: Mosaic partial trisomy 2p: completion of chromosomal characterization 17 years after initial visit. Am J Hum Genet 61, Suppl:A372 (1997).
  5. Doray B, Favre R, Gasser B, Girard-Lemaire F, Schluth C, Flori E: Recurrent neural tube defects associated with partial trisomy 2p22-pter: report of two siblings and review of the literature. Genet Couns 14:165-172 (2003).
    External Resources
  6. Dowa Y, Yamamoto T, Abe Y, Kobayashi M, Hoshino R, et al: Congenital neuroblastoma in a patient with partial trisomy of 2p. J Pediatr Hematol Oncol 28:379-382 (2006).
  7. Fineman RM, Buyse M, Morgan M: Variable phenotype associated with duplication of different regions of 2p. Am J Med Genet 15:451-456 (1983).
  8. Gregory L, Davis T, Bonney J, Delmege D, Skirton H, Lunt P: Trisomy for the region 2p25.2 to 2pter with a variable phenotype. J Med Genet 37, Suppl 1:S52 (2000).
  9. Hahm GK, Barth RF, Schauer GM, Reiss R, Opitz JM: Trisomy 2p syndrome: a fetus with anencephaly and postaxial polydactyly. Am J Med Genet 87:45-48 (1999).
  10. Heathcote JG, Sholdice J, Walton JC, Willis NR, Sergovich FR: Anterior segment mesenchymal dysgenesis associated with partial duplication of the short arm of chromosome 2. Can J Ophthalmol 26:35-43 (1991).
    External Resources
  11. Kan ASY, Lau ET, Tang WF, Chan SSY, Ding SCK, et al: Whole-genome array CGH evaluation for replacing prenatal karyotyping in Hong Kong. PLoS One 9:e87988 (2014).
  12. Kim SJ, Kim MJ, Kim MS, Park IY, Hur SY, et al: Prenatal 3D-ultrasound diagnosis of exencephaly associated with partial trisomy 2p and distal 5p deletion. Acta Obstetr Gynaecol Japon 59:775, abstract P1-IS-53 (2007).
  13. Larson LM, Wasdahl WA, Saumur JH, Coleman ML, Hall JG, et al: Familial reciprocal translocation, t(2;10)(p24;q26), resulting in duplication 2p and deletion 10q. Clin Genet 21:187-195 (1982).
  14. León León C, Velázquez Wong AC, Rodríguez Palacios ME, Huicochea Montiel JC, Cárdenas Conejo A, et al: Trisomía parcial de 2p y monosomía parcial de 18p con presencia de dysplasia septoóptica. Asociation Mexicana de Genetica Humana, XXXVI Congresso, Abstract CG6 (2011).
  15. Lipska BS, Koczkowska M, Wierzba J, Ploszynska A, Iliszko M, et al: On the significance of germline cytogenetic rearrangements at MYCN locus in neuroblastoma. Mol Cytogenet 6:43 (2013).
  16. Lurie IW, Ilyina HG, Gurevich DB, Rumyantseva NV, Naumchik IV, et al: Trisomy 2p: analysis of unusual phenotypic findings. Am J Med Genet 55:229-236 (1995).
  17. Martínez-Juárez A, Uribe-Figueroa L, Quintana-Palma M, Razo-Aguilera G, Sevilla-Montoya R: Pure trisomy 2p syndrome in two siblings with an unbalanced translocation and minimal terminal 12q monosomy characterized by high-density microarray. Cytogenet Genome Res 142:249-254 (2014).
  18. Morgenstern DA, Soh SY, Stavropoulos DJ, Bowdin S, Baruchel S, et al: Metachronous neuroblastoma in an infant with germline translocation resulting in partial trisomy 2p: a role for ALK? J Pediatr Hematol Oncol 36:e193-e196 (2014).
  19. Mosca AL, Pinson L, Andrieux J, Copin H, Bigi N, et al: Refining the critical region for congenital diaphragmatic hernia on chromosome 15q26 from the study of four fetuses. Prenat Diagn 31:912-914 (2011).
  20. Nagano H, Kano Y, Kobuchi S, Kajitani T: A case of partial 2p trisomy with neuroblastoma. Jpn J Hum Genet 25:39-45 (1980).
  21. Nowaczyk MJM, Huggins MJ, Tomkins DJ, Rossi E, Woulfe J, et al: Holoprosencephaly, sacral anomalies, and situs ambiguous in an infant with partial monosomy 7q/trisomy 2p and SHH and HLXB9 haploinsufficiency. Clin Genet 57:388-393 (2000).
  22. Patel JS, Pearson J, Willatt L, Andrews T, Beach R, Green A: Germline duplication of chromosome 2p and neuroblastoma. J Med Genet 34:949-951 (1997).
  23. Poulose T, Tsepov D, Fox R: Familial exencephaly-anencephaly sequence and translocation. J Obstet Gynaecol 27:317-318 (2007).
  24. Quintana Palma M, Martínez-Juárez A, Razo Aguilera G, Grether González P, Nieto Martínez K, et al: Características fenotípicas en una pareja de hermanos con trisomía parcial 2p y monosomía parcial 12q resultants de una translocación maternal balanceada 2;12(p22.2;q24.31). Asociation Mexicana de Genetica Humana, XXXV Congresso, Abstract (2010).
  25. Sarda P, Lefort G, Devaux P, Huneau C, Rieu D: Multiple congenital anomalies due to partial 2p13→2pter duplication resulting from an unbalanced X;2 translocation. Ann Genet 35:117-120 (1992).
    External Resources
  26. Say B, Carpenter NJ, Giacoia G, Jegathesan S: Agenesis of the lung associated with a chromosomal abnormality (46,XX,2p+). J Med Genet 17:477-478 (1980).
  27. Singer N, Gersen S, Warburton D: The value of chromosome analysis in cases of neural tube defects: a case of anencephaly associated with fetal dup(2)(p24→pter). Prenat Diagn 7:567-571 (1987).
  28. Stallworth JL, Avert JM, DuPont BR, Lebel RR: Partial trisomy 2p and partial monosomy 9p in a fetus with anencephaly, polydactyly, and other abnormalities. Proc Greenwood Genet Center 27:18-21 (2008).
  29. Stephane R, Genevieve D, Sanlaville D, Maltret A, Serrero S, et al: Trisomy 2p and monosomy 8p in a patient with DiGeorge syndrome. Am J Hum Genet 75, Suppl:266 (2003).
  30. Thangavelu M, Frolich G, Rogers D: Partial duplication 2p as the sole abnormality in two cases with anencephaly. Am J Med Genet A 124A: 170-172 (2004).
  31. Therkelsen AJ, Hultén M, Jonasson J, Lindsten J, Christensen NC, Iversen T: Presumptive direct insertion within chromosome 2 in man. Ann Hum Genet 36:367-373 (1973).
  32. Van Mater D, Knelson EH, Kaiser-Rogers KA, Armstrong MB: Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locus. Am J Med Genet A 161A:605-610 (2013).
  33. Walbaum R, Peyrat MF, van de Velde MF, Guerin du Masgenet B, Bethouart M, Farriaux JP: Fail-il caryotyper les parents d'enfants atteints d'anomalies de fermeture du tube neural? J Genet Hum 32:307 (1984).
  34. Warad D, Kirmani S, Marri Reddy P, Nemergut M, Rodriguez V, Nageswara Rao A: Perinatal neuroblastoma with a germline interstitial 2p duplication involving the MYCN gene: a case report. Arch Dis Child 97 (Suppl 2):A161-A162 (2012).
    External Resources
  35. Wellesley D, Boyle T: Regarding trisomy 2p syndrome. Am J Med Genet 92:295 (2000).
  36. Winsor SH, McGrath MJ, Khalifa M, Duncan AM: A report of recurrent anencephaly with trisomy 2p23-2pter: additional evidence for the involvement of 2p24 in neural tube development and evaluation of the role for cytogenetic analysis. Prenat Diagn 17:665-669 (1997).
  37. Yüksel A, Seven M, Karaman B, Yilmaz S, Deviren A, et al: Neuroblastoma in a dysmorphic girl with a partial duplication of 2p caused by an unbalanced translocation. Clin Dysmorphol 11:39-42 (2002).
Tables
Thumbnail
Thumbnail
Thumbnail
TOP